President, Asian Society for Neuro-Oncology (ASNO)
Dear Friends
It is a great honour to serve as President of the Asian Society for Neuro-Oncology
(ASNO). I am grateful for the trust
placed in me and privileged to represent a vibrant community dedicated to improving the
lives of patients with brain and
central nervous system tumours across Asia and Oceania.
Our region bears a significant proportion of the global neuro-oncology burden, yet it is
also one of immense opportunity. While our countries differ in healthcare systems,
resources, cultures, and patient populations, we are united by a shared commitment to
advancing research, education, innovation, and patient care. It is this spirit that has
guided ASNO since its inception in 2002 and continues to shape our future.
ASNO has grown into a leading regional platform for scientific exchange and
international collaboration, working closely with partner organisations including the
Society for Neuro-Oncology (SNO) and the European Association of Neuro-Oncology (EANO).
Through collaborative research, education, mentorship, and multidisciplinary
partnerships, we aim to generate evidence that reflects the unique needs of our diverse
populations while nurturing the next generation of neuro-oncology leaders.
It is therefore particularly fitting that the 22nd Annual Meeting of the Asian Society
for Neuro-Oncology (ASNO) will be held jointly with the 18th Annual Meeting of the
Indian Society of Neuro-Oncology (ISNO) in Jaipur, India, from 4–7 March 2027, under the
theme "Unity in Diversity." This landmark joint meeting represents a unique opportunity
to bring together regional and national expertise on a single platform, fostering
stronger collaborations across disciplines, institutions, and countries. By uniting
ASNO's international network with ISNO's vibrant and rapidly growing neuro-oncology
community, we aspire to create an enriching scientific programme that reflects the
diversity, innovation, and shared aspirations of our region.
India, home to one of the world's most diverse healthcare ecosystems, embodies the
spirit of "Unity in Diversity." Jaipur, the iconic Pink City of Rajasthan, beautifully
blends centuries of heritage with innovation and warm hospitality, offering an inspiring
setting for scientific exchange and lasting friendships. Just as India's strength lies
in its diversity, so too does the strength of ASNO. Together, our varied experiences,
perspectives, and expertise will enable us to address the unique challenges of
neuro-oncology across Asia and Oceania.
The scientific programme will showcase the latest advances spanning molecular
diagnostics, precision oncology, neurosurgery, radiation oncology, systemic therapies,
paediatric neuro-oncology, survivorship, supportive care, and quality of life. More
importantly, it will provide opportunities to build enduring collaborations, exchange
regional experiences, and inspire innovations that improve patient outcomes throughout
our region.
As we gather in Jaipur, let us celebrate not only the diversity of our nations but also
the unity of our purpose to advance neuro-oncology through collaboration, excellence,
and compassion.
On behalf of ASNO and ISNO, I warmly invite you to join us in Jaipur for this landmark
joint meeting. Together, let us transform our diversity into collective strength and our
shared vision into meaningful progress for every patient with a brain tumour,
irrespective of geography or circumstance.
I look forward to welcoming you to Jaipur for what promises to be an outstanding
scientific, educational, and cultural experience.
With warm regards,